Overview:

Recent advances in molecular testing and targeted therapies have rapidly transformed care for non–small cell lung cancer (NSCLC), making personalized management possible across all disease stages. However, significant challenges persist in the early detection of actionable mutations, comprehensive biomarker testing, and the integration of novel agents with unique efficacy and toxicity profiles into everyday practice.

This live webinar series brings together expert faculty for interactive, case-based discussions tailored to community oncology practice. Participants will gain practical insights on implementing biomarker-driven strategies, selecting optimal therapies, and managing adverse events, enhancing confidence in advancing NSCLC care for diverse patient populations.

Learning Objectives:

Upon completion of this activity, learners will be better able to:

• Evaluate key biomarkers and their role in guiding targeted therapy selection in NSCLC
• Implement molecular testing strategies to identify actionable mutations in clinical practice 
• Apply clinical trial evidence supporting the efficacy and safety of targeted therapies in NSCLC to manage patients with NSCLC with actionable mutations optimally
• Identify optimal strategies to manage adverse events associated with novel targeted therapies in NSCLC

Target Audience:

This educational program is primarily directed toward community-based oncologists involved in the treatment of NSCLC.

Accreditation/Credit Designation:

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hour. 

Acknowledgment of Educational Support

This activity is supported by educational grants from Exact Sciences Corporation; Lilly; Nuvation Bio; Partner Therapeutics.

Have a question for the PER® team?

Email: info@gotoper.com